Alkermes Issues Letter to Shareholders Highlighting Skills a

Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) (the Company) today issued a letter to its shareholders in connection with the Company's upcoming 2023 Annual...

Related Keywords

Iron Mountain , New York , United States , Dublin , Ireland , Ohio , Athlone , Westmeath , Massachusetts , Canada , Innisfree , Sligo , Waltham , Irish , Davida Daglio , Wilda Van Dusen , W Montague Cobb , Nancyj Wysenski , Eli Lilly , Shanem Cooke , Emily Peterson , Andy Wilson , Richard Gaynor , Katie Joyce , Catot Laurencin , Frank Anders Wilson , Alexander Denner , Sarahj Schlesinger , Nancyl Snyderman , America Ph , David Daglio , Christopher Wright , Shane Cooke , Sarah Schlesinger , Brianp Mckeon , Alexj Denner , Cato Laurencin , Chris Kittredge Zachary Tramonti , Patrice Bonfiglio , Brian Mckeon , Emily Peterson Alva , Richardb Gaynor , Christopheri Wright , Nancy Wysenski , Professor Of Neurology At Harvard Medical School , Pembroke Capital , Clinical Development , Neon Therapeutics Inc , Africana Studies Institute , Infinity Pharmaceuticals Inc , Catot Laurencin Institute For Regenerative Engineering , Emergent Biosolutions Inc , Prothena Corporation , Biotechnology Innovation Organization , Acadia Pharmaceuticals Inc , University Of Connecticut Uconn , Elan Corporation , Leap Therapeutics Inc , Health Institute , Mimedx Group Inc , Company Annual Report On Form , Affairs Of Lilly Oncology , Vertex Pharmaceuticals Incorporated , Corporate Governance Committee , Axcella Health Inc , Lazard , Laboratories Inc , Harvard Medical School Board Of Fellows , Aavantibio Inc , Acceleron Pharma Inc , Jazz Pharmaceuticals , Exelixis Inc Incyte Corporation , School Of Medicine , Sage Therapeutics Inc , Head Of Translational Research Ring Therapeutics , Damon Runyon Cancer Research Foundation , United Therapeutics Corporation , Sarepta Therapeutics Inc , Mission Society Of New York City , Ultragenyx Pharmaceutical Inc , Pepsico Inc , National Health Council , Therapeutics Inc , Zai Lab , Alnylam Pharmaceuticals Inc , Company Or Alkermes , University Professor , Ethnic Health Disparities , Global Medicines Development , Endo International , Neurocrine Biosciences Inc , Biontech Us Inc , Ironwood Pharmaceuticals Inc , Cyclerion Therapeutics Inc , Epizyme Inc , Timberland Company , Nasdaq , Iron Mountain Incorporated , Denner , Nominees On Company , Ionis Pharmaceuticals Inc , Exchange Commission , Blueprint Medicines Corporation , Alkermes , Innisfree Ma Incorporated , Amneal Pharmaceuticals Inc , Shareholders Vote , Director Nominees , General Meeting , Annual Meeting , Alkerme Value Enhancement Plan , Sarissa Capital Management , Richard Pops , Alkermes Shareholder , Value Enhancement Plan , Annual General Meeting , Elliott Management , Lead Independent , Key Roles , Advisory Experience , Amneal Pharmaceuticals , Emission Society , New York City , Elan Drug Technologies , Executive Vice President , Chief Financial Officer , Chief Executive , Pembroke Capital Limited , Neon Therapeutics , Senior Vice President , Medical Affairs , Lilly Oncology , Simmons Cancer Center , Texas Southwestern Medical School , Infinity Pharmaceuticals , Zai Lab Limited , Leap Therapeutics , Wilda Van Dusen Distinguished Endowed Professor , Orthopaedic Surgery , Biomolecular Engineering , Materials Science , Biomedical Engineering , Chief Executive Officer , Regenerative Engineering , Founding Chair , Mimedx Group , Vice President , North America , Prescription Drug User Fee Act , Polaris Venture Partners , Harvard Medical School Board , Neurocrine Biosciences , Pharmaceutical Research , Acceleron Pharma , Chief Medical Officer , Translational Research , Ring Therapeutics , Cyclerion Therapeutics , Chief Development Officer , Ironwood Pharmaceuticals , Axcella Health , Associate Professor , Harvard Medical School , Scientific Advisor , Interactions Between Sarissa , Alkermes Independent Directors , Lead Independent Director Nancy Wysenski , Sarissa Designee , Sarissa Nominees , Chief Investment Officer , Current Refreshed Board , Not Truly Independent , Current Refreshed , Alkerme Board , Alkermes Board , Private Securities Litigation Reform Act , Annual Report , Additional Information , Alnylam Pharmaceuticals , Incyte Corporation , Ionis Pharmaceuticals , Sage Therapeutics , Sarepta Therapeutics , United Therapeutics ,

© 2024 Vimarsana